Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China · Delayed Price · Currency is CNY 245.71
+4.94 (2.05%)
At close: Oct 30, 2026
SHA:688506 Market Cap
SHA:688506 has a market cap or net worth of 100.77 billion as of October 30, 2026. It is the 1,483rd most valuable company in the world and the 118th biggest in China. Its market cap has decreased by 28.99% in one year.
Market Cap
100.77B
Enterprise Value
97.04B
Revenue
2.55B
Global Rank
Country Rank
#118 China
PE Ratio
n/a
ChartMarket Cap Chart
Since January 6, 2023, SHA:688506's market cap has increased from 12.85B to 100.77B, an increase of 684.08%. That is a compound annual growth rate of 71.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 100.77B | -24.46% |
| Dec 31, 2025 | 133.40B | 73.51% |
| Dec 31, 2024 | 76.88B | 37.05% |
| Dec 29, 2023 | 56.10B | 336.51% |
| Jan 6, 2023 | 12.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 319.39B |
| Yunnan Baiyao Group Co.,Ltd | 95.83B |
| Zhejiang NHU Company | 78.50B |
| Shanghai Fosun Pharmaceutical (Group) | 55.50B |
| Huadong Medicine | 46.68B |
| China Resources Sanjiu Medical & Pharmaceutical | 42.07B |
| Beijing Tongrentang | 34.38B |
| Shenzhen Salubris Pharmaceuticals | 33.07B |